Brain Damage-linked ATP Promotes P2X7 Receptors Mediated Pineal N-acetylserotonin Release

Kassiano S Sousa1, Caroline L Quiles1, Sandra M Muxel1

  • 1Laboratory of Chronopharmacology, Department of Physiology, Institute of Bioscience, University of São Paulo, São Paulo 05508-090, Brazil.

Neuroscience
|July 7, 2022
PubMed

Insights

The pineal gland uses ATP to regulate melatonin (MEL) production. Low ATP boosts MEL, while high ATP converts N-acetylserotonin (NAS) to MEL, aiding brain injury responses.

Area of Science:

  • Neuroendocrinology
  • Cellular signaling
  • Immunology

Background:

  • The pineal gland produces melatonin (MEL), which regulates leukocyte activity.
  • Melatonin synthesis is inhibited by inflammatory signals, promoting leukocyte migration.
  • Adenosine triphosphate (ATP) modulates noradrenaline (NAd)-induced MEL synthesis via P2Y1 receptors and inhibits N-acetylserotonin (NAS) to MEL conversion via P2X7 receptors.

Purpose of the Study:

  • To investigate the effects of focal ATP increases on pineal gland activity and melatonin synthesis in vivo.
  • To elucidate the role of ATP signaling through P2Y1 and P2X7 receptors in regulating melatonin production and its precursors.
  • To understand the pineal gland's response to cellular damage signals within the brain.

Main Methods:

  • Adult rats received intraventricular injections of varying ATP doses (0.3, 1.0, 3.0 µg) and a P2X7 receptor agonist (BzATP).
  • Pineal gland and blood samples were analyzed for melatonin (MEL) and N-acetylserotonin (NAS) content.
  • Gene expression of melatonergic enzymes in different brain structures (cortex, cerebellum) was assessed.

Main Results:

  • Low ATP doses (0.3, 1.0 µg) increased nocturnal pineal MEL output.
  • High ATP dose (3.0 µg) and BzATP administration elevated NAS levels in both the pineal gland and blood.
  • Cortical MEL levels increased, while cerebellar MEL remained unchanged, indicating structure-dependent responses.
  • Changes in gene expression of synthetic and metabolizing melatonergic enzymes correlated with observed MEL and NAS levels.

Conclusions:

  • The pineal gland responds to focal increases in brain ATP, modulating melatonin synthesis.
  • ATP signaling via P2X7 receptors plays a critical role in converting NAS to MEL, particularly under conditions of cellular damage.
  • The pineal gland acts as a first-line sensor for brain cell death, utilizing the NAS-to-MEL pathway.

Related Concept Videos

The Pineal Gland01:02

The Pineal Gland

The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
2.4K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
13.0K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.5K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K